Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson's disease.

Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson's disease.

A higher levodopa dose is a strong risk factor for levodopa-induced dyskinesia (LID) in patients with Parkinson's disease (PD). However, levodopa dose can change during long-term medication. We explored the relationship between levodopa dose and time to onset of LID using longitudinal multicent...

Bibliografski detalji
Glavni autori:	Jin Yong Hong, Mun Kyung Sunwoo, Jung Han Yoon, Suk Yun Kang, Young H Sohn, Phil Hyu Lee, Seo Hyun Kim
Format:	Članak
Jezik:	English
Izdano:	Public Library of Science (PLoS) 2020-01-01
Serija:	PLoS ONE
Online pristup:	https://doi.org/10.1371/journal.pone.0237472

Slični predmeti

White matter hyperintensities and risk of levodopa‐induced dyskinesia in Parkinson’s disease
od: Seok Jong Chung, i dr.
Izdano: (2020-02-01)

Contracted thalamic shape is associated with early development of levodopa-induced dyskinesia in Parkinson’s disease
od: Han Soo Yoo, i dr.
Izdano: (2022-07-01)

Comparison of endothelial progenitor cells in Parkinson's disease patients treated with levodopa and levodopa/COMT inhibitor.
od: Phil Hyu Lee, i dr.
Izdano: (2011-01-01)

Future Scenarios for Levodopa-induced Dyskinesias in Parkinson’s disease
od: Antonio eCerasa, i dr.
Izdano: (2015-04-01)

BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease.
od: Foltynie, T, i dr.
Izdano: (2009)

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
od: Alejandro Martinez-Carrasco, i dr.
Izdano: (2023-08-01)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
od: Bargiotas P, i dr.
Izdano: (2013-10-01)

Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?
od: Paolo Calabresi, i dr.
Izdano: (2019-12-01)

Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
od: J. Guridi, i dr.
Izdano: (2012-01-01)

Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies
od: Destany K. Kwon, i dr.
Izdano: (2022-11-01)

Pallidal Structural Changes Related to Levodopa-induced Dyskinesia in Parkinson's Disease
od: Jinyoung Youn, i dr.
Izdano: (2022-05-01)

The features of sensorimotor integration in patients with levodopa-induced dyskinesia in Parkinson’s disease
od: Olga A. Alenikova, i dr.
Izdano: (2017-02-01)

Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease
od: Eva König, i dr.
Izdano: (2021-10-01)

Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson’s Disease
od: Tianbin Song, i dr.
Izdano: (2021-03-01)

Vision-based assessment of parkinsonism and levodopa-induced dyskinesia with pose estimation
od: Michael H. Li, i dr.
Izdano: (2018-11-01)

Sleepiness and Depression in Parkinson’s Disease Patients Treated with Ropinirole and Levodopa
od: Suk Yun Kang, i dr.
Izdano: (2017-09-01)

Apathy and Olfactory Dysfunction in Early Parkinson’s Disease
od: Jin Yong Hong, i dr.
Izdano: (2015-01-01)

Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study
od: Bruno Lopes Santos-Lobato, i dr.
Izdano: (2023-05-01)

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
od: Nayron Medeiros Soares, i dr.
Izdano: (2023-01-01)

Brain-Region Specific Metabolic Abnormalities in Parkinson’s Disease and Levodopa-Induced Dyskinesia
od: Changwei Yang, i dr.
Izdano: (2020-03-01)

Analysis of Genetic and Non-genetic Predictors of Levodopa Induced Dyskinesia in Parkinson’s Disease
od: Alfonsina Tirozzi, i dr.
Izdano: (2021-04-01)

Investigation of <i>PRKN</i> Mutations in Levodopa-Induced Dyskinesia in Parkinson’s Disease Treatment
od: Ana Gabrielle Bispo, i dr.
Izdano: (2023-08-01)

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease
od: Sharma VD, i dr.
Izdano: (2018-04-01)

Blood Flow and Glucose Metabolism Dissociation in the Putamen Is Predictive of Levodopa Induced Dyskinesia in Parkinson's Disease Patients
od: Maram Aljuaid, i dr.
Izdano: (2019-11-01)

Clinical Aspects and Management of Levodopa-Induced Dyskinesia
od: Nicola Tambasco, i dr.
Izdano: (2012-01-01)

Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats
od: Chang-Qing Zheng, i dr.
Izdano: (2021-06-01)

Dysregulation of BET proteins in levodopa-induced dyskinesia
od: David A. Figge, i dr.
Izdano: (2017-06-01)

Radiomics and Hybrid Models Based on Machine Learning to Predict Levodopa-Induced Dyskinesia of Parkinson’s Disease in the First 6 Years of Levodopa Treatment
od: Yang Luo, i dr.
Izdano: (2023-07-01)

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
od: Maria Sheila G. Rocha, i dr.
Izdano: (1995-12-01)

Altered perivascular spaces in subcortical white matter in Parkinson’s disease patients with levodopa-induced dyskinesia
od: Xingyue Cao, i dr.
Izdano: (2024-03-01)

Dose–response relationship of levodopa with dyskinesia in Parkinson's disease: A systematic review and meta-analysis
od: Taozhi He, i dr.
Izdano: (2024-03-01)

Levodopa-Responsive Early-Onset Parkinsonism in Down Syndrome
od: Padmini Palat, i dr.
Izdano: (2018-01-01)

Levodopa Dose-Limiting Dyskinesias in Treatment of Segawa Disease
od: J Gordon Millichap
Izdano: (2012-07-01)

Levodopa-induced belly dancer's dyskinesia: Case report
od: José Renan Miranda Cavalcante-Filho, i dr.
Izdano: (2020-01-01)

Striatal Synaptic Dysfunction in Dystonia and Levodopa-Induced Dyskinesia
od: Mariangela Scarduzio, i dr.
Izdano: (2022-05-01)

Persistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter Imaging.
od: Jin Yong Hong, i dr.
Izdano: (2016-01-01)

Functional motor network abnormalities associated with levodopa-induced dyskinesia in Parkinson’s disease: A systematic review
od: Birgitte Liang Chen Thomsen, i dr.
Izdano: (2024-01-01)

Dyskinesia-hyperpyrexia syndrome in Parkinson's disease triggered by overdose of levodopa — a case report and literature review
od: Xiangnan Du, i dr.
Izdano: (2024-01-01)

Cognitive impairment and levodopa induced dyskinesia in Parkinson’s disease: a longitudinal study from the PACOS cohort
od: Antonina Luca, i dr.
Izdano: (2021-01-01)

Levodopa-induced dyskinesia in early-onset Parkinson’s disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand
od: Sekh Thanprasertsuk, i dr.
Izdano: (2023-01-01)